AU2001266271A1 - Compound screens relating to insulin deficiency or insulin resistance - Google Patents
Compound screens relating to insulin deficiency or insulin resistanceInfo
- Publication number
- AU2001266271A1 AU2001266271A1 AU2001266271A AU6627101A AU2001266271A1 AU 2001266271 A1 AU2001266271 A1 AU 2001266271A1 AU 2001266271 A AU2001266271 A AU 2001266271A AU 6627101 A AU6627101 A AU 6627101A AU 2001266271 A1 AU2001266271 A1 AU 2001266271A1
- Authority
- AU
- Australia
- Prior art keywords
- insulin
- deficiency
- screens relating
- compound screens
- insulin resistance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/60—New or modified breeds of invertebrates
- A01K67/61—Genetically modified invertebrates, e.g. transgenic or polyploid
- A01K67/63—Genetically modified worms
- A01K67/64—Genetically modified nematodes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/60—New or modified breeds of invertebrates
- A01K67/61—Genetically modified invertebrates, e.g. transgenic or polyploid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0014009 | 2000-06-08 | ||
| GBGB0014009.5A GB0014009D0 (en) | 2000-06-08 | 2000-06-08 | Compound screens relating to insulin deficiency or insulin resistance |
| PCT/IB2001/001199 WO2001093669A2 (en) | 2000-06-08 | 2001-06-08 | Compound screens relating to insulin deficiency or insulin resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001266271A1 true AU2001266271A1 (en) | 2001-12-17 |
Family
ID=9893260
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001266274A Abandoned AU2001266274A1 (en) | 2000-06-08 | 2001-06-08 | Assay techniques based on growth stage dependent expression inc. elegans |
| AU2001266271A Abandoned AU2001266271A1 (en) | 2000-06-08 | 2001-06-08 | Compound screens relating to insulin deficiency or insulin resistance |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001266274A Abandoned AU2001266274A1 (en) | 2000-06-08 | 2001-06-08 | Assay techniques based on growth stage dependent expression inc. elegans |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20040073956A1 (en) |
| EP (2) | EP1287354A2 (en) |
| JP (2) | JP2004500866A (en) |
| AU (2) | AU2001266274A1 (en) |
| GB (1) | GB0014009D0 (en) |
| WO (2) | WO2001094627A2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050014264A1 (en) * | 2002-12-11 | 2005-01-20 | University Of Massachusetts | Method of introducing siRNA into adipocytes |
| US7435868B2 (en) | 2003-01-30 | 2008-10-14 | Sanofi-Aventis Deutschland Gmbh | Screening assay based on the forkhead transcription factor-dependent sod-3 promoter |
| DE10303850A1 (en) * | 2003-01-30 | 2004-08-12 | Aventis Pharma Deutschland Gmbh | Screening assay based on the forkhead transcription factor dependent sod-3 promoter to identify AKT modulating compounds or upstream regulators such as insulin / IGF1 receptors |
| MXPA06011694A (en) | 2004-04-09 | 2006-12-14 | Monsanto Technology Llc | COMPOSITIONS AND METHODS FOR CONTROL OF INSECT INFOSTATIONS IN PLANTS. |
| US8759306B2 (en) | 2005-05-31 | 2014-06-24 | Devgen N.V. | RNAi for the control of insects and arachnids |
| WO2010151625A1 (en) * | 2009-06-25 | 2010-12-29 | Fred Hutchinson Cancer Research Center | Methods for treating and diagnosing glucose metabolic syndrome |
| WO2016126026A2 (en) * | 2015-02-04 | 2016-08-11 | 서울대학교병원 | Composition for treating diabetes and use thereof |
| US10184104B2 (en) * | 2015-11-19 | 2019-01-22 | Alexander Lee Lianides | Automated system for cultivating transgenic C. elegans |
| EP3415601A1 (en) | 2017-06-15 | 2018-12-19 | The Procter & Gamble Company | Water-soluble unit dose article comprising a solid laundry detergent composition |
| EP3415606A1 (en) | 2017-06-15 | 2018-12-19 | The Procter & Gamble Company | Water-soluble unit dose article comprising a solid laundry detergent composition |
| US10550357B2 (en) | 2017-06-15 | 2020-02-04 | The Procter & Gamble Company | Water-soluble unit dose article comprising a solid laundry detergent composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6376239B1 (en) * | 1997-04-04 | 2002-04-23 | Elegene Gmbh | DNA molecules comprising a promoter capable of conferring expression of a heterologous DNA sequence |
| AU752962B2 (en) * | 1997-05-15 | 2002-10-03 | General Hospital Corporation, The | Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| US6861256B2 (en) * | 1997-05-15 | 2005-03-01 | The General Hospital Corporation | Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| DE19727962A1 (en) * | 1997-07-02 | 1999-01-14 | Juergen Hescheler | Fluorescent proteins as cell type-specific reporters |
-
2000
- 2000-06-08 GB GBGB0014009.5A patent/GB0014009D0/en not_active Ceased
-
2001
- 2001-06-08 JP JP2002502167A patent/JP2004500866A/en active Pending
- 2001-06-08 EP EP01943746A patent/EP1287354A2/en not_active Withdrawn
- 2001-06-08 JP JP2002501246A patent/JP2003534815A/en active Pending
- 2001-06-08 EP EP01943743A patent/EP1287353A2/en not_active Withdrawn
- 2001-06-08 WO PCT/IB2001/001213 patent/WO2001094627A2/en not_active Ceased
- 2001-06-08 US US10/297,192 patent/US20040073956A1/en not_active Abandoned
- 2001-06-08 AU AU2001266274A patent/AU2001266274A1/en not_active Abandoned
- 2001-06-08 US US10/297,336 patent/US20050229260A1/en not_active Abandoned
- 2001-06-08 WO PCT/IB2001/001199 patent/WO2001093669A2/en not_active Ceased
- 2001-06-08 AU AU2001266271A patent/AU2001266271A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003534815A (en) | 2003-11-25 |
| EP1287353A2 (en) | 2003-03-05 |
| WO2001093669A3 (en) | 2002-05-10 |
| GB0014009D0 (en) | 2000-08-02 |
| US20040073956A1 (en) | 2004-04-15 |
| US20050229260A1 (en) | 2005-10-13 |
| AU2001266274A1 (en) | 2001-12-17 |
| WO2001093669A2 (en) | 2001-12-13 |
| EP1287354A2 (en) | 2003-03-05 |
| WO2001094627A2 (en) | 2001-12-13 |
| JP2004500866A (en) | 2004-01-15 |
| WO2001094627A3 (en) | 2002-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001237298A1 (en) | Panel element | |
| AU2002227514A1 (en) | Collaborative filtering | |
| AU2001281997A1 (en) | Glazing | |
| AU2002359200A1 (en) | New composition | |
| AU2001282271A1 (en) | Double glazing | |
| AU2002241114A1 (en) | Composition | |
| AU2002349673A1 (en) | Insulin resistance improving agents | |
| AU2001266271A1 (en) | Compound screens relating to insulin deficiency or insulin resistance | |
| AU2001241098A1 (en) | Composition | |
| EP1168892A3 (en) | EL element | |
| AU2001264109A1 (en) | Parasiticidal composition | |
| AU2003205858A1 (en) | "long"-"acting" injectable parasiticidal composition | |
| AU2001275201A1 (en) | Acne-treating composition | |
| AU3775200A (en) | Construction element | |
| AU2001287852A1 (en) | Composition | |
| AU3846500A (en) | Curtain assembly | |
| AU2001287732A1 (en) | Copolycarbonate-based composition | |
| AUPQ246999A0 (en) | Insecticidal composition | |
| AU2001287642A1 (en) | Glazing | |
| AU2001262163A1 (en) | Composition | |
| AU2001267554A1 (en) | Glazing | |
| AU2002324206A1 (en) | Improvements in or relating to insecticide screening | |
| AU2001264110A1 (en) | Parasiticidal composition | |
| AU2001236079A1 (en) | Intermediate compounds | |
| AU2003203518A1 (en) | Improvements to insect screens |